| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-08-04 20:31 Tx date 2021-07-30 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+14,309 vol |
577,739 | |
| Filed 2021-05-07 16:59 Tx date 2021-05-03 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$103,499
+75,000 vol $1.38 each |
405,000 | |
| Filed 2021-05-06 10:10 Tx date 2021-05-06 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-14,400
-30,000 vol $0.48 each |
300,000 | |
| Filed 2021-05-05 22:20 Tx date 2021-04-30 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+13,974 vol |
563,430 | |
| Filed 2021-03-02 21:41 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Indirect Ownership)
|
Common Shares (Class A)
54 - Exercise of warrants
|
$32,500
+10,000 vol $3.25 each |
34,000 | |
| Filed 2021-03-02 21:35 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-32,500
-10,000 vol $3.25 each |
0 | |
| Filed 2021-03-02 21:30 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-32,500
-10,000 vol $3.25 each |
||
| Filed 2021-03-02 21:29 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
54 - Exercise of warrants
|
$32,500
+10,000 vol $3.25 each |
||
| Filed 2021-03-02 20:47 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-32,500
-10,000 vol $3.25 each |
-10,000 | |
| Filed 2021-03-02 20:47 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-32,500
-10,000 vol $3.25 each |
||
| Filed 2021-03-02 20:42 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
54 - Exercise of warrants
|
$32,500
+10,000 vol $3.25 each |
1,250,000 | |
| Filed 2021-03-02 20:42 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
54 - Exercise of warrants
|
$32,500
+10,000 vol $3.25 each |
||
| Filed 2021-02-03 20:34 Tx date 2021-01-29 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+11,718 vol |
549,456 | |
| Filed 2020-11-04 18:29 Tx date 2020-10-30 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+13,823 vol |
537,738 | |
| Filed 2020-08-06 07:33 Tx date 2020-07-31 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+15,287 vol |
523,915 | |
| Filed 2020-06-08 12:14 Tx date 2020-06-04 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Indirect Ownership)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$2,200
+10,000 vol $0.22 each |
10,000 | |
| Filed 2020-06-08 12:04 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-08 11:51 Tx date 2020-06-04 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Indirect Ownership)
|
Common Shares (Class A)
15 - Acquisition or disposition under a prospectus
|
$47,800
+20,000 vol $2.39 each |
24,000 | |
| Filed 2020-05-05 20:42 Tx date 2020-05-01 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$78,750
+75,000 vol $1.05 each |
330,000 | |
| Filed 2020-05-05 20:38 Tx date 2020-04-30 |
$
Zenith Capital Corp. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Units Restricted Share Units
46 - Compensation for services
|
+17,383 vol |
508,628 |